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remind us that we are working with the same goals, though
in different environments, but that our patient needs
remain constant.
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Cinacalcet and cardiovascular
mortality in hemodialysis patients
To the Editor: I read with interest the observational study of
Block et al.1 suggesting that cinacalcet hydrochloride
signiﬁcantly improves cardiovascular survival in hemodialysis
patients. Inasmuch as the authors note that survival appears
improved with lower serum calcium and phosphorus
levels, the implication of the data cited is that upregulation
of the calcium-sensing receptor may be involved in the
improved outcome.
I bring to your attention work of our group2 in a sheep
burn model and of another group in the spontaneously
hypertensive rat3 in which the calcium receptor has been
identiﬁed in heart endocardial epithelium, microvasculature
of the myocardium, and aortic endothelium and adventitia
by ﬂuorescence deconvolution microscopy2 and in the rat
vascular smooth muscle.3
Although experiments showing a dialysis-associated down-
regulation of the cardiovascular calcium-sensing receptor
have not as yet been reported to my knowledge, the
combination of the observational data reported by Block
et al.1 and the experiments localizing the calcium-sensing
receptor to the cardiovascular system2,3 warrant that the
status of the receptor be documented in a dialysis model as an
important step in understanding the pathophysiology of the
cardiovascular complications of dialysis.
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